Larimar Therapeutics Inc (LRMR)
R&D Expenses
$28.00M
Quarterly · Period ending: · USD
LRMR R&D Expenses
Latest reported$28.00Mperiod ending
Latest reported$28.00Mperiod ending
LRMR Quarterly R&D Expenses ($4.70M → $28.00M)
Quarterly R&D Expenses
High-resolution chart · PNG
LRMR r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 28,000,000 | |
| 25,031,000 | |
| 59,373,000 | |
| 44,931,000 | |
| 23,368,000 | |
| 26,552,000 | |
| 26,738,000 | |
| 13,919,000 | |
| 19,682,000 | |
| 12,859,000 | |
| 10,567,000 | |
| 6,585,000 | |
| 5,875,000 | |
| 4,562,000 | |
| 7,218,000 | |
| 5,582,000 | |
| 5,644,000 | |
| 5,806,000 | |
| 6,292,000 | |
| 14,028,000 | |
| 9,102,000 | |
| 8,974,000 | |
| 10,574,000 | |
| 6,919,000 | |
| 8,907,000 | |
| 5,007,000 | |
| 5,406,000 | |
| 8,034,000 | |
| 3,128,000 | |
| 4,222 | |
| 11,457,000 | |
| 11,830,000 | |
| 12,209,000 | |
| 12,433,000 | |
| 10,911,000 | |
| 9,723,000 | |
| 10,528,000 | |
| 9,677,000 | |
| 7,275,000 | |
| 10,001,000 | |
| 10,163,000 | |
| 12,497,000 | |
| 17,706,000 | |
| 14,171,000 | |
| 12,526,000 | |
| 10,215,000 | |
| 12,076,000 | |
| 4,695,000 |